中文
| Catalogue |
|
|
| Recommend Products |
MetP Pharma AG
Switzerland, Manufacturer, Hits: 6, Updated:7/9/2025
Schynweg 7 Office: St. Anna-Weg 16 P.O.Box 138 6376 Emmetten / Switzerland |
Company Profile
-
MetP? Pharma AG is an independent pharmaceutical R&D and product development company based in Switzerland, specializing in nose-to-brain drug delivery. The company’s proprietary MetP? Technology is a comprehensively patented platform that enables direct, efficient delivery of therapeutics to the brain, bypassing the blood-brain barrier.
The brain-targeting capabilities of MetP? Technology have been validated by several independent research institutions worldwide and are featured in 67 predominantly peer-reviewed publications. The platform has proven its clinical utility in several preclinical and clinical trials and has demonstrated to be fast, safe, effective, user-friendly, and cost-efficient.
MetP? is actively advancing its own pipeline of intranasal therapeutics targeting conditions such as concussion, insomnia, ADHD, multiple sclerosis (MS), and hypogonadism. A strong global intellectual property portfolio protects the platform until 2037/2039.
Beyond formulation, MetP? offers an integrated, end-to-end solution including its proprietary unit-dose applicator and industrial-scale filling technology - providing partners with a fully developed, patent-protected, and ready-to-use drug delivery system.